Pharmicell Co., Ltd. (005690.KS)
005690.KS Stock Price Chart
Explore Pharmicell Co., Ltd. interactive price chart. Choose custom timeframes to analyze 005690.KS price movements and trends.
005690.KS Company Profile
Discover essential business fundamentals and corporate details for Pharmicell Co., Ltd. (005690.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
4 Jan 2000
Employees
136.00
Website
https://www.pharmicell.comCEO
Hyun-Soo Kim
Description
Pharmicell Co., Ltd., a biopharmaceutical company, develops and sells stem cell drugs in South Korea and internationally. The company operates in Biopharmaceutical Business and Biochemical Business divisions. It offers Cellgram_AMI that is manufactured using autologous bone marrow-derived mesenchymal stem cell to enhance the ejection fraction in patients with acute myocardial infarction reperfused by coronary angioplasty. The company's products under development include Cellgram_LC, a liver disease drug; Cellgram_ED for treating impotence; and Cellgram_DC, a cancer drug, as well as Hearticellgram_AM, a cardiac disease drug. It also develops and produces intermediates of raw material medicines, such as nucleosides, mPEGs, HDP-tosylate, and vincelactam; and low dielectric constant material, eco-friendly flame retardant, polyol synthesis catalyst, PET catalyst, etc. In addition, the company operates Twelve, a stem cell bank; develops and sells stem cell culture media cosmetics. Pharmicell Co., Ltd. was founded in 2002 and is headquartered in Seoul, South Korea.
005690.KS Financial Timeline
Browse a chronological timeline of Pharmicell Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 9 Feb 2026
Upcoming earnings on 4 Nov 2025
Earnings released on 11 Aug 2025
Earnings released on 8 May 2025
EPS came in at ₩141.00 , while revenue for the quarter reached ₩27.03B .
Earnings released on 10 Feb 2025
EPS came in at ₩69.23 , while revenue for the quarter reached ₩21.47B .
Dividend declared on 27 Dec 2024
A dividend of ₩20.00 per share was announced, adjusted to ₩20.00. The dividend was paid on 26 Mar 2025.
Earnings released on 6 Nov 2024
EPS came in at ₩12.00 , while revenue for the quarter reached ₩14.59B .
Earnings released on 13 Aug 2024
EPS came in at ₩47.13 , while revenue for the quarter reached ₩17.81B .
Earnings released on 15 May 2024
EPS came in at -₩22.74 , while revenue for the quarter reached ₩10.97B , beating expectations by +10.03K%.
Earnings released on 20 Mar 2024
EPS came in at ₩20.55 , while revenue for the quarter reached ₩13.21B .
Earnings released on 9 Nov 2023
EPS came in at ₩17.84 , while revenue for the quarter reached ₩12.17B .
Earnings released on 11 Aug 2023
EPS came in at ₩9.59 , while revenue for the quarter reached ₩17.74B .
Earnings released on 15 May 2023
EPS came in at ₩18.05 , while revenue for the quarter reached ₩13.11B , beating expectations by +15.96K%.
Earnings released on 6 Feb 2023
EPS came in at -₩74.00 , while revenue for the quarter reached ₩11.93B .
Earnings released on 21 Nov 2022
EPS came in at ₩64.64 , while revenue for the quarter reached ₩17.26B .
Earnings released on 16 Aug 2022
EPS came in at ₩37.26 , while revenue for the quarter reached ₩13.57B .
Earnings released on 9 May 2022
EPS came in at ₩82.24 , while revenue for the quarter reached ₩17.42B .
Earnings released on 15 Mar 2022
EPS came in at ₩31.20 , while revenue for the quarter reached ₩11.80B .
Earnings released on 9 Nov 2021
EPS came in at ₩60.00 , while revenue for the quarter reached ₩13.17B .
Earnings released on 17 Aug 2021
EPS came in at ₩36.00 , while revenue for the quarter reached ₩13.77B .
Earnings released on 11 May 2021
EPS came in at ₩32.00 , while revenue for the quarter reached ₩12.16B .
Earnings released on 8 Feb 2021
EPS came in at ₩11.45 , while revenue for the quarter reached ₩8.97B .
Earnings released on 11 Nov 2020
EPS came in at ₩12.00 , while revenue for the quarter reached ₩7.88B .
005690.KS Stock Performance
Access detailed 005690.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.